Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET HORIZON trial of rocatinlimab, an investigational therapy targeting the OX40 receptor (OX40R) in patients with ...
Forward Medical, a leading innovator in plastic surgery, aesthetic surgery, and dermatology products, participated in the ...
21h
TD Cowen 45th Annual Health Care Conference, March 3-5, 2025 Event details: Date: Monday, March 3, 2025 Time: 2:30 pm ET Location: Boston, MA Participants may access a live webcast of the event by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback